Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617

Radiobiology for the Radiologist.

(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498

Untitled work

(1989) · PubMed · Cited by 3,343

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300

The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy

Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,891

HIF-1: mediator of physiological and pathophysiological responses to hypoxia

Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822

Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.

Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727

The urokinase plasminogen activator system: a target for anti-cancer therapy

Ulisse, S., Baldini, E., Sorrenti, S., & D'Armiento, M. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787314002 · Cited by 312

Redox mechanisms switch on hypoxia-dependent epithelial–mesenchymal transition in cancer cells

Cannito, S., Novo, E., Compagnone, A., di Bonzo, L. V., Busletta, C., Zamara, E., Paternostro, C., Povero, D., Bandino, A., Bozzo, F., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn216 · Cited by 319

Investigating hypoxic tumor physiology through gene expression patterns

Denko, N. C., Fontana, L., Hudson, K. M., Sutphin, P. D., Raychaudhuri, S., Altman, R. B., & Giaccia, A. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206703 · Cited by 313

Cancer Stem Cells and Radioresistance: DNA Repair and Beyond

Schulz, A., Meyer, F., Dubrovska, A., & Borgmann, K. (2019) · Cancers · doi:10.3390/cancers11060862 · Cited by 317

Tumor hypoxia and cancer progression

Zhou, J., Schmid, T., Schnitzer, S. E., & Brüne, B. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.05.028 · Cited by 306

Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways

Masson, N., & Ratcliffe, P. J. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-3 · Cited by 305

Why develop photoactivated chemotherapy?

Bonnet, S. A. (2018) · Dalton Transactions · doi:10.1039/c8dt01585f · Cited by 300

Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H2O2 and Catalase for Enhanced Radio-Immunotherapy of Cancer

Song, X., Xu, J., Liang, C., Chao, Y., Jin, Q., Wang, C., Chen, M., & Liu, Z. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b02720 · Cited by 299

Recent advances in luminescent heavy metal complexes for sensing

Ma, D., Ma, V. P., Chan, D. S., Leung, K., He, H., & Leung, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.07.005 · Cited by 299

Immunometabolism in early and late stages of rheumatoid arthritis

Weyand, C. M., & Goronzy, J. J. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.49 · Cited by 296

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

Bidlingmaier, S. M., Zhu, X., & Liu, B. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0357-8 · Cited by 287

Regulation of the multidrug resistance transporter P‐glycoprotein in multicellular tumor spheroids by hypoxia‐inducible factor‐1 and reactive oxygen species

Wartenberg, M., Ling, F. C., Müschen, M., Klein, F., Acker, H., Gassmann, M., Petrat, K., Pütz, V., Hescheler, J., & Sauer, H. (2003) · The FASEB Journal · doi:10.1096/fj.02-0358fje · Cited by 287

Regulation of reactive oxygen species in stem cells and cancer stem cells

Kobayashi, C. I., & Suda, T. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22764 · Cited by 298

Negative and positive regulation of HIF-1: A complex network

Bárdos, J. I., & Ashcroft, M. A. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.05.001 · Cited by 287

Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis

El-Naggar, A. M., Veinotte, C. J., Cheng, H., Grünewald, T. G. P., Negri, G. L., Somasekharan, S. P., Corkery, D., Tirode, F., Mathers, J. A., Khan, D., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.003 · Cited by 288

Hypoxia Positron Emission Tomography Imaging With 18F-Fluoromisonidazole

Lee, S. T., & Scott, A. M. (2007) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2007.07.001 · Cited by 283

Up-down regulation of HIF-1α in cancer progression

Rashid, M., Zadeh, L. R., Baradaran, B., Molavi, O., Ghesmati, Z., Sabzichi, M., & Ramezani, F. (2021) · Gene · doi:10.1016/j.gene.2021.145796 · Cited by 302

Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study

Vergis, R., Corbishley, C. M., Norman, A. R., Bartlett, J., Jhavar, S., Borre, M., Heeboll, S., Horwich, A., Huddart, R., Khoo, V., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70076-7 · Cited by 282

IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism

Grassian, A. R., Parker, S. J., Davidson, S. M., Divakaruni, A. S., Green, C. R., Zhang, X., Slocum, K. L., Pu, M., Lin, F., Vickers, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0772-t · Cited by 280

FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2

Bakker, W. J., Harris, I. S., & Mak, T. W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.10.035 · Cited by 277

Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers

Bussink, J., Kaanders, J. H. A. M., & van der Kogel, A. J. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(03)00011-2 · Cited by 280

Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival

Spence, A. M., Muzi, M., Swanson, K. R., O’Sullivan, F., Rockhill, J. K., Rajendran, J. G., Adamsen, T. C. H., Link, J. M., Swanson, P. E., Yagle, K. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4995 · Cited by 282

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial

Overgaard, J., Eriksen, J. G., Nordsmark, M., Alsner, J., & Horsman, M. R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70292-8 · Cited by 274

Regulation of Angiogenesis by Hypoxia and Hypoxia‐Inducible Factors

Hickey, M. M., & Simon, M. C. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)76007-0 · Cited by 273

The mechanisms by which polyamines accelerate tumor spread

Soda, K. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-95 · Cited by 276

Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms

Zi, Y., Yang, K., He, J., Wu, Z., Liu, J., & Zhang, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114449 · Cited by 268

Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy

Gao, S., Wang, G., Qin, Z., Wang, X., Zhao, G., Ma, Q., & Zhu, L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.030 · Cited by 260

Hypoxia induces a novel signature of chromatin modifications and global repression of transcription

Johnson, A. B., Denko, N., & Barton, M. C. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.01.001 · Cited by 250

Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities

Kirtane, A. R., Kalscheuer, S., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 264

Selective removal of mitochondria via mitophagy: distinct pathways for different mitochondrial stresses

Wei, H., Liu, L., & Chen, Q. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.03.013 · Cited by 266

ARCON: a novel biology-based approach in radiotherapy

Kaanders, J. H., Bussink, J., & van der Kogel, A. J. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00929-4 · Cited by 257

Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy

Yang, S., & Gao, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.004 · Cited by 256

Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer

Generali, D., Berruti, A., Brizzi, M. P., Campo, L., Bonardi, S., Wigfield, S., Bersiga, A., Allevi, G., Milani, M., Aguggini, S., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2690 · Cited by 253

Exosomes: Key mediators of metastasis and pre-metastatic niche formation

Lobb, R. J., Lima, L. G., & Möller, A. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.01.004 · Cited by 252

The biology of extracellular microvesicles

Sedgwick, A., & D’Souza‐Schorey, C. (2018) · Traffic · doi:10.1111/tra.12558 · Cited by 257

Construction of nanomaterials with targeting phototherapy properties to inhibit resistant bacteria and biofilm infections

Wang, Y., Jin, Y., Chen, W., Wang, J., Chen, H., Sun, L. N., Li, X., Ji, J., Yu, Q., Shen, L., et al. (2018) · Chemical Engineering Journal · doi:10.1016/j.cej.2018.10.002 · Cited by 245

Carbon dots: a booming material for biomedical applications

Su, W., Wu, H., Xu, H., Zhang, Y., Li, Y., Li, X., & Fan, L. (2019) · Materials Chemistry Frontiers · doi:10.1039/c9qm00658c · Cited by 244

Microenvironmental and cellular consequences of altered blood flow in tumours

Raghunand, N., Gatenby, R. A., & Gillies, R. J. (2003) · British Journal of Radiology · doi:10.1259/bjr/12913493 · Cited by 240

Silencing of the Hypoxia-Inducible Cell Death Protein BNIP3 in Pancreatic Cancer

Okami, J., Simeone, D. M., & Logsdon, C. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0089 · Cited by 237

Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs

Phillips, R. M. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2920-7 · Cited by 248

Cycling hypoxia: A key feature of the tumor microenvironment

Michiels, C., Tellier, C., & Féron, O. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.06.004 · Cited by 244

Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates

Hewitson, K. S., Liénard, B. M. R., McDonough, M. A., Clifton, I. J., Butler, D., Soares, A. S., Oldham, N. J., McNeill, L. A., & Schofield, C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608337200 · Cited by 235

Antiangiogenic therapy and tumor progression

Blagosklonny, M. V. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00336-2 · Cited by 238

The Coppery Age: Copper (Cu)‐Involved Nanotheranostics

Dong, C., Feng, W., Xu, W., Yu, L., Xiang, H., Chen, Y., & Zhou, J. (2020) · Advanced Science · doi:10.1002/advs.202001549 · Cited by 236

Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment

Kanapathipillai, M., Brock, A., & Ingber, D. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.005 · Cited by 234

Silver Nanoplate Contrast Agents for in Vivo Molecular Photoacoustic Imaging

Homan, K. A., Souza, M., Truby, R. L., Luke, G. P., Green, C., Vreeland, E. C., & Emelianov, S. (2011) · ACS Nano · doi:10.1021/nn204100n · Cited by 233

Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors

Supuran, C. T. (2017) · Metabolites · doi:10.3390/metabo7030048 · Cited by 234

Photoacoustic Imaging for Cancer Detection and Staging

Mehrmohammadi, M., Yoon, S. J., Yeager, D., & Emelianov, S. (2013) · Current molecular imaging · doi:10.2174/2211555211302010010 · Cited by 232

Ketogenic Diets Enhance Oxidative Stress and Radio-Chemo-Therapy Responses in Lung Cancer Xenografts

Allen, B. G., Bhatia, S. K., Buatti, J. M., Brandt, K. E., Lindholm, K. E., Button, A. M., Szweda, L. I., Smith, B. J., Spitz, D. R., & Fath, M. A. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0287 · Cited by 232

Three-dimensional multispecies nonlinear tumor growth—II: Tumor invasion and angiogenesis

Frieboes, H. B., Jin, F., Chuang, Y.-L., Wise, S. M., Lowengrub, J. S., & Vittorio Cristini, C. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.02.036 · Cited by 236

Hepatocyte growth factor and the Met system as a mediator of tumor–stromal interactions

Matsumoto, K., & Nakamura, T. (2006) · International Journal of Cancer · doi:10.1002/ijc.21808 · Cited by 237

Differential prognostic impact of hypoxia induced and diffuse HIF-1α expression in invasive breast cancer

Vleugel, M. M., Greijer, A. E., Shvarts, A., van der Groep, P., van Berkel, M., Aarbodem, Y., van Tinteren, H., Harris, A. L., van Diest, P. J., & van der Wall, E. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.019885 · Cited by 227

The Warburg effect: Evolving interpretations of an established concept

Chen, X., Qian, Y., & Wu, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.027 · Cited by 234

Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways

Sørensen, B. S., & Horsman, M. R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00562 · Cited by 241

Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids

Riffle, S., & Hegde, R. S. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0570-9 · Cited by 231

The A3 adenosine receptor: An enigmatic player in cell biology

Gessi, S., Merighi, S., Varani, K., Leung, E., Lennan, S. M., & Borea, P. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.002 · Cited by 225

Adenosine receptors and cancer

Gessi, S., Merighi, S., Sacchetto, V., Simioni, C., & Borea, P. A. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.09.020 · Cited by 229

Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications

Gallez, B., Baudelet, C., & Jordan, B. F. (2004) · NMR in Biomedicine · doi:10.1002/nbm.900 · Cited by 225

Ratiometric Molecular Sensor for Monitoring Oxygen Levels in Living Cells

Yoshihara, T., Yamaguchi, Y., Hosaka, M., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107557 · Cited by 222

Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging

Fink, J. R., Muzi, M., Peck, M., & Krohn, K. A. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.131516 · Cited by 230

Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia

Cao, X., Fang, L., Gibbs, S. T., Huang, Y. S., Dai, Z., Wen, P., Zheng, X., Sadée, W., & Sun, D. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0291-9 · Cited by 222

GLUT‐1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding

Airley, R. E., Loncaster, J. A., Raleigh, J. A., Harris, A. L., Davidson, S. E., Hunter, R. D., West, C., & Stratford, I. J. (2003) · International Journal of Cancer · doi:10.1002/ijc.10904 · Cited by 220

Hypoxia Stimulates Carcinoma Invasion by Stabilizing Microtubules and Promoting the Rab11 Trafficking of the α6β4 Integrin

Yoon, S.-O., Shin, S., & Mercurio, A. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4122 · Cited by 226

Curcumin Inhibits Hypoxia-Inducible Factor-1 by Degrading Aryl Hydrocarbon Receptor Nuclear Translocator: A Mechanism of Tumor Growth Inhibition

Choi, H., Chun, Y., Kim, S.-W., Kim, M.-S., & Park, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025817 · Cited by 219

Hypoxia Inhibits Protein Synthesis through a 4E-BP1 and Elongation Factor 2 Kinase Pathway Controlled by mTOR and Uncoupled in Breast Cancer Cells

Connolly, E. P., Braunstein, S. E., Formenti, S. C., & Schneider, R. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.10.3955-3965.2006 · Cited by 227

Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo

Attalla, S. S., Taifour, T., Bui, T., & Muller, W. J. (2020) · Oncogene · doi:10.1038/s41388-020-01560-0 · Cited by 215

Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia

Sahu, A., Kwon, I., & Tae, G. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119578 · Cited by 219

Fluence rate as a modulator of PDT mechanisms

Henderson, B. W., Busch, T. M., & Snyder, J. W. (2006) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20327 · Cited by 217

Acute vs. Chronic vs. Cyclic Hypoxia: Their Differential Dynamics, Molecular Mechanisms, and Effects on Tumor Progression

Saxena, K., & Jolly, M. K. (2019) · Biomolecules · doi:10.3390/biom9080339 · Cited by 223

Modulation of in Vivo Tumor Radiation Response via Gold Nanoshell-Mediated Vascular-Focused Hyperthermia: Characterizing an Integrated Antihypoxic and Localized Vascular Disrupting Targeting Strategy

Diagaradjane, P., Shetty, A., Wang, J. C., Elliott, A. M., Schwartz, J., Shentu, S., Park, H. C., Deorukhkar, A., Stafford, R. J., Cho, S. H., et al. (2008) · Nano Letters · doi:10.1021/nl080496z · Cited by 215

Controllable Generation of Nitric Oxide by Near‐Infrared‐Sensitized Upconversion Nanoparticles for Tumor Therapy

Zhang, X., Tian, G., Yin, W., Wang, L., Zheng, X., Yan, L., Li, J., Su, H., Chen, C., Gu, Z., et al. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201404402 · Cited by 215

Targeting the hypoxia-inducible factor (HIF) pathway in cancer

Poon, E., Harris, A. L., & Ashcroft, M. A. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001173 · Cited by 215

RBE and related modeling in carbon-ion therapy

Karger, C. P., & Peschke, P. (2017) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aa9102 · Cited by 224

Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming

Chae, Y. C., Vaira, V., Caino, M. C., Tang, H., Seo, J. H., Kossenkov, A. V., Ottobrini, L., Martelli, C., Lucignani, G., Bertolini, I., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.07.004 · Cited by 214

Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.

Olive, P. L., Aquino‐Parsons, C., MacPhail, S. H., Liao, S. Y., Raleigh, J. A., Lerman, M. I., & Stanbridge, E. J. (2001) · PubMed · Cited by 206

Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors

Jögi, A., Vaapil, M., Johansson, M., & Påhlman, S. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.659294 · Cited by 209

Hypoxia‐inducible factor‐1 and oncogenic signalling

Bárdos, J. I., & Ashcroft, M. A. (2004) · BioEssays · doi:10.1002/bies.20002 · Cited by 208

Clinical photoacoustic imaging platforms

Choi, W., Park, E.-Y., Jeon, S., & Kim, C. (2018) · Biomedical Engineering Letters · doi:10.1007/s13534-018-0062-7 · Cited by 204

Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302

Meng, F., Evans, J., Bhupathi, D., Banica, M., Lan, L., Lorente, G., Duan, J.-X., Cai, X., Mowday, A. M., Guise, C. P., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0634 · Cited by 205

Modulating tumor hypoxia by nanomedicine for effective cancer therapy

Jahanban‐Esfahlan, R., de la Guardia, M., Ahmadi, D., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25859 · Cited by 201

Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1α and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells

Zhang, Q., Tang, X., Lu, Q., Zhang, Z., Brown, J. J., & Le, A. D. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0198 · Cited by 205

Molecular imaging of hypoxia with radiolabelled agents

Mees, G., Dierckx, R. A. J. O., Vangestel, C., & de Wiele, C. V. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1195-9 · Cited by 201

Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides

Vullo, D., Franchi, M., Gallori, E., Pastorek, J., Scozzafava, A., Pastoreková, S., & Supuran, C. T. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00091-x · Cited by 201

Hypoxic tumor microenvironment: Opportunities to develop targeted therapies

Patel, A., & Sant, S. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.04.005 · Cited by 205

The von Hippel–Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis

Pugh, C. W., & Ratcliffe, P. J. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00103-7 · Cited by 205

Redox sensor CtBP mediates hypoxia-induced tumor cell migration

Zhang, Q., Wang, S.-Y., Nottke, A. C., Rocheleau, J. V., Piston, D. W., & Goodman, R. H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603269103 · Cited by 200

Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability

Pires, I. M., Bencokova, Z., Milani, M., Folkes, L. K., Li, J., Stratford, M. R., Harris, A. L., & Hammond, E. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2715 · Cited by 209

Prediction of Tumor Recurrence and Therapy Monitoring Using Ultrasound-Guided Photoacoustic Imaging

Mallidi, S., Watanabe, K., Timerman, D., Schoenfeld, D., & Hasan, T. G. (2015) · Theranostics · doi:10.7150/thno.10155 · Cited by 200

Solid tumor physiology and hypoxia-induced chemo/radio-resistance: Novel strategy for cancer therapy: Nitric oxide donor as a therapeutic enhancer

Yasuda, H. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.026 · Cited by 199

Targeting amino acid metabolism in cancer growth and anti-tumor immune response

Ananieva, E. A. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i4.281 · Cited by 203

The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance

Kharaishvili, G., Simkova, D., Bouchalova, K., Gachechiladze, M., Narsia, N., & Bouchal, J. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-41 · Cited by 197

Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice

Quennet, V., Yaromina, A., Zips, D., Rosner, A., Walenta, S., Baumann, M. A., & Mueller‐Klieser, W. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.08.012 · Cited by 197

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Borad, M. J., Reddy, S. G., Bahary, N., Uronis, H. E., Sigal, D., Cohn, A. L., Schelman, W. R., Stephenson, J., Chiorean, E. G., Rosen, P. J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.7504 · Cited by 197

PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence.

Lopci, E., Grassi, I., Chiti, A., Nanni, C., Cicoria, G., Toschi, L., Fonti, C., Lodi, F., Mattioli, S., & Fanti, S. (2014) · PubMed Central · Cited by 196

Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy

Li, Y., Patel, S. P., Roszik, J., & Qin, Y. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01591 · Cited by 203

Current and future trends in photoacoustic breast imaging

Manohar, S., & Dantuma, M. (2019) · Photoacoustics · doi:10.1016/j.pacs.2019.04.004 · Cited by 193

The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy

Tan, E. Y., Yan, M., Campo, L., Han, C., Takano, E. A., Turley, H., Candiloro, I. L. M., Pezzella, F., Gatter, K. C., Millar, E. K. A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604844 · Cited by 195

Recent development of luminescent rhenium( i ) tricarbonyl polypyridine complexes as cellular imaging reagents, anticancer drugs, and antibacterial agents

Lee, L. C., Leung, P. K., & Lo, K. K. (2017) · Dalton Transactions · doi:10.1039/c7dt03465b · Cited by 197

Hypoxia-Inducible Erythropoietin Signaling in Squamous Dysplasia and Squamous Cell Carcinoma of the Uterine Cervix and Its Potential Role in Cervical Carcinogenesis and Tumor Progression

Ács, G., Zhang, P. J., McGrath, C. M., Acs, P. I., McBroom, J. W., Mohyeldin, A., Liu, S., Lu, H., & Verma, A. M. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64314-3 · Cited by 194

HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase

Sendoel, A., Köhler, I., Fellmann, C., Lowe, S. W., & Hengartner, M. O. (2010) · Nature · doi:10.1038/nature09141 · Cited by 191

Characterization of tumor hypoxia by 31P MR spectroscopy.

Steen, R. G. (1991) · American Journal of Roentgenology · doi:10.2214/ajr.157.2.1853799 · Cited by 28

The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities

Walsh, J. C., Lebedev, A. Y., Aten, E., Madsen, K. S., Marciano, L., & Kolb, H. C. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5378 · Cited by 432

Hypoxia-induced tumor biological behavior changes and application of radiotracers for PET imaging of tumor hypoxia

Zhang, M., Jiang, H., & Xu, H. (2017) · doi:10.3760/cma.j.issn.1671-7368.2017.07.021

Determination of the dynamics of tumor hypoxia during radiation therapy using biological imaging on mouse xenograft tumors

Maftei, C. (2013)

Hypoxia PET/CT imaging: implications for radiation oncology.

Arabi, M., & Piert, M. (2010) · PubMed · Cited by 28